Specifically, the presence of heterogeneity in hENT1 expression within a tumor can pose challenges when assessing hENT1 expression through immunohistochemistry on single biopsy samples, as the results may not accurately represent the overall hENT1 expression profile of the entire tumor (Walter et al., 2017). Here, SLC29A1 is linked to neoplasm.